Dynavax Technologies Corporation (NASDAQ: DVAX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced positive interim data from a clinical trial over the weekend. Of course, the news has excited investors who are sending the stock on a run for the top. Today, we’ll talk … Read more
Dynavax Technologies Corporation (NASDAQ: DVAX) is having an overwhelmingly strong start to the trading session this morning after releasing new data at an annual research meeting. Of course, the positive data led to strong statements by analysts in the audience and excitement among investors, sending the stock upward. Today, we’ll talk about: The data; what … Read more
Dynavax Technologies Corporation (NASDAQ: DVAX) is having an incredibly strong time in the pre-market hours this morning, and for good reason. The company announced that it has received approval from the FDA surrounding a key clinical candidate. Of course, this led to excitement among investors, sending the stock screaming toward the top. Today, we’ll talk … Read more
Dynavax Technologies Corporation (NASDAQ: DVAX) is having an incredibly rough time in the market today, and for good reason. The company announced the pricing of a previously announced public offering, leading to some concerns among investors. Of course, this sent the value of the stock tumbling, prompting an alert from our friends at Trade Ideas. … Read more
Dynavax Technologies Corporation (NASDAQ: DVAX) is off to an incredibly rough start in the pre-market hours this morning, and for good reason. The company announced news it received from the FDA. Unfortunately, this news proved to be concerning to investors. Of course, this led to declines, prompting our partners at Trade Ideas to alert us … Read more
Dynavax Technologies Corporation (NASDAQ: DVAX) is off to an incredibly strong start in the pre-market this morning, and for good reason. The company announced the results of the FDA advisory committee meeting surrounding Heplisav-B, and those results proved to be positive. Of course, this led to excitement among investors who are sending the stock toward … Read more
Dynavax Technologies Corporation (NASDAQ: DVAX) is off to a rough day in the market today, and for good reason. The FDA has released briefing documents with regard to an upcoming VRBPAC meeting surrounding the potential approval of the company’s Hepatitis B Vaccine. Unfortunately, there is one primary concern that seems to be frightening investors. Of … Read more
Dynavax Technologies Corporation (NASDAQ: DVAX) is off to an incredibly strong start in the trading session today, and for good reason. Early this morning, the company informed investors of an FDA advisory committee review of an experimental drug. Of course, this led to excitement among investors, sending the value of the stock toward the top. … Read more
Dynavax Technologies Corporation (NASDAQ: DVAX) Dynavax Technologies wasn’t off to the best of starts in the trading session today. When the opening bell rang, the stock was already slightly in the red. From there, we’ve seen a steady continuation of declines bringing the stock further down into the abyss. However, news just came down the … Read more
Dynavax Technologies Corporation (NASDAQ: DVAX) Dynavax Technologies is having an incredibly rough day in the market today, and for good reason. The company has received damning news from the FDA, causing investors to drop the stock like it’s hot. Today, we’ll talk about what we’re seeing from the stock, why, and what we’ll be watching … Read more